Skip to main content

View full-text article in PMC

. 2020 Dec 2;20:316. doi: 10.1186/s12890-020-01351-z

Table 5.

Comparison of treatment outcome of active and subclinical tuberculosis diseases among the drug-susceptible cohort

	Active TB disease (n = 308)	Subclinical TB disease (n = 75)	p value
Mortality^a
Number (%)	26 (8.4%)	1 (1.3%)	0.031^e
OR (95% CI)	Reference	0.15 (0.02–1.10)	0.054
Adjusted OR^d (95% CI)	Reference	0.21 (0.03–1.61)	0.123
Treatment success^b
Number (%)	252 (81.8%)	67 (89.3%)	0.118^e
OR (95% CI)	Reference	0.54 (0.24–1.18)	0.122
Adjusted OR^d (95% CI)	Reference	0.63 (0.28–1.41)	0.259
Favourable outcome^c
Number (%)	246 (79.9%)	67 (89.3%)	0.057^e
OR (95% CI)	Reference	0.47 (0.21–1.04)	0.062
Adjusted OR^d (95% CI)	Reference	0.53 (0.24–1.18)	0.122

TB tuberculosis, OR odds ratio, CI confidence interval

^aIncidence of mortality during or before anti-TB treatment

^bSum of cured and treatment completed cases within 1 year of anti-TB treatment

^cSum of treatment success and no recurrence

^dAdjusted by age and gender

^eChi-square test